Annals of Allergy, Asthma and Immunology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
P229
VALUES AND PREFERENCES OF PATIENTS AND CAREGIVERS REGARDING TREATMENT OF ATOPIC DERMATITIS: A SYSTEMATIC REVIEW
2022
-
HAMILTON STOCK EPINEPHRINE PILOT STUDY: A SURVEY OF CANADIANS DINING IN A FOOD COURT
2016
-
LOCAL ADVERSE REACTIONS DECREASED OVER TIME DURING IGHY TREATMENT IN PATIENTS WITH PIDD
2016
-
A CASE OF HASHIMOTO'S ENCEPHALOPATHY TREATED WITH IMMUNOMODULATION AND THYROIDECTOMY WITH INCIDENTAL FINDING OF THYROID CANCER.
2014
-
RECONCILIATION OF HEALTH RECORDS FOLLOWING PENICILLIN ALLERGY TESTING OF HOSPITALIZED PATIENTS.
2014
-
INTERNATIONAL PRACTICE OF SELF-ADMINISTRATION IN THE MANAGEMENT OF HEREDITARY ANGIOEDEMA: SURVEY RESULTS AND DISCUSSION FROM AN INTERNATIONAL EXPERT PANEL
2013
-
OMALIZUMAB TREATMENT FOR ASTHMA IN PATIENTS WITH LOW TOTAL IGE
2013
-
THE ALLERGIC RHINITIS CLINICAL INVESTIGATOR COLLABORATIVE-CYTOKINE PROFILING OF SYNTHETIC ABSORPTIVE MATRIX ELUATES TO OPTIMIZE A STANDARD NASAL ALLERGEN CHALLENGE PROTOCOL
2013
-
Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma
2008
-
Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunology 133 (2024) 286-94]>..
S1081-1206(24)01630-2.
2024
-
Symptomatology and management of peanut anaphylaxis: A cross-sectional study..
S1081-1206(24)01536-9.
2024
-
Management of anaphylaxis after pre-hospital epinephrine use in children with food-induced anaphylaxis..
S1081-1206(24)01528-X.
2024
-
You do not get to choose your nightmares: They choose you..
133:238-239.
2024
-
Clinical characteristics and management of pediatric egg-induced anaphylaxis: A cross-sectional study.
133:81-85.e2.
2024
-
A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology.
133:286-294.
2024
-
Oral food immunotherapy in patients with atopic dermatitis.
133:278-283.
2024
-
Topical corticosteroids for hives and itch (urticaria): Systematic review and Bayesian meta-analysis of randomized trials.
133:437-444.e18.
2024
-
Managing the packing list for college when it includes subcutaneous allergen immunotherapy.
132:566-568.
2024
-
Milk-induced anaphylaxis among children presenting to Canadian emergency departments.
132:512-518.e1.
2024
-
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations.
132:274-312.
2024
-
Anaphylaxis: A 2023 practice parameter update.
132:124-176.
2024
-
Managing anaphylaxis.
131:752-758.e1.
2023
-
LEUKOTRIENE RECEPTOR ANTAGONISTS WITH ANTIHISTAMINES VERSUS ANTIHISTAMINES ALONE FOR CHRONIC URTICARIA: SYSTEMATIC REVIEW AND META-ANALYSIS.
131:S230-S230.
2023
-
The promise and peril of knowledge translation for food allergy prevention.
131:544-546.
2023
-
A comparison of the effectiveness of biologic therapies for asthma.
130:595-606.
2023
-
The need for change.
130:542-543.
2023
-
Allergies don't take a vacation.
130:419-421.
2023
-
An allergist's approach to food poisoning.
130:444-451.
2023
-
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
130:60-66.
2023
-
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials.
129:758-768.e4.
2022
-
CANCER RISK WITH TOPICAL PIMECROLIMUS AND TACROLIMUS FOR ATOPIC DERMATITIS: SYSTEMATIC REVIEW AND BAYESIAN META-ANALYSIS.
129:S7-S7.
2022
-
Sesame-induced anaphylaxis in pediatric patients from the cross-Canada anaphylaxis registry.
129:342-346.
2022
-
Tree nut-induced anaphylaxis in Canadian emergency departments: Rate, clinical characteristics, and management.
129:335-341.
2022
-
Economic burden of food allergy in Canada.
129:220-230.e6.
2022
-
Bleach baths for atopic dermatitis.
128:660-668.e9.
2022
-
Seafood-induced anaphylaxis in children presenting to Canadian emergency departments.
128:583-588.
2022
-
Peanut cross-contamination in randomly selected baked goods.
128:439-442.
2022
-
Demographic and clinical characteristics of patients with hereditary angioedema in Canada.
128:89-94.e1.
2022
-
Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
127:165-175.e1.
2021
-
Quality of life in patients with hereditary angioedema in Canada.
126:394-400.e3.
2021
-
Cosegregation of postural orthostatic tachycardia syndrome, hypermobile Ehlers-Danlos syndrome, and mast cell activation syndrome.
125:719-720.
2020
-
P231 TRIPLE THERAPY (ICS/LABA/LAMA) IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
125:S37-S38.
2020
-
A counseling video with pre- and posttesting and checklist for oral immunotherapy consent improves participant knowledge.
125:468-474.e4.
2020
-
Asthma maintenance and reliever therapy.
125:150-155.
2020
-
Intentional poisoning with peanut as a cause of recurrent anaphylaxis.
124:622-623.
2020
-
Making the GRADE in anaphylaxis management.
124:526-535.e2.
2020
-
Epinephrine autoinjectors.
124:449-450.
2020
-
Decades of poor availability of epinephrine autoinjectors.
124:205-207.e1.
2020
-
ICER report for peanut OIT comes up short.
123:430-432.
2019
-
Implications of variation of epinephrine auto-injector needle length.
123:89-94.
2019
-
Point-of-care ultrasonography in the allergy and immunology clinic.
123:42-47.
2019
-
Authors’ response.
121:644-645.
2018
-
Canadian physician survey on the medical management of hereditary angioedema.
121:598-603.
2018
-
Epinephrine auto-injector needle lengths: Can both subcutaneous and periosteal/intraosseous injection be avoided?.
120:648-653.e1.
2018
-
Late presentation of subtotal C6 deficiency in a patient with recurrent Neisseria meningitides infections.
120:432-433.
2018
-
Can the atopic march be predicted?.
120:115-116.
2018
-
Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma.
120:59-65.e2.
2018
-
Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers.
118:719-725.e1.
2017
-
The PD 20 but not the PC 20 in a methacholine challenge test is device independent.
118:508-509.
2017
-
Administering multiple cumulative allergen challenges.
117:326-328.
2016
-
Evaluating a handbook for parents of children with food allergy: a randomized clinical trial.
116:230-236.e1.
2016
-
Venom allergy testing: is a graded approach necessary?.
116:49-51.
2016
-
Emerging therapeutic options for the treatment of patients with symptomatic asthma.
115:265-271.e5.
2015
-
Assessing asthma in African American children using the Asthma Control Test and the Childhood Asthma Control Test.
114:342-344.
2015
-
Likelihood of being prescribed an epinephrine autoinjector in allergic Canadians with lower educational levels.
113:326-329.
2014
-
Interleukin-18 expression, CD8+ T cells, and eosinophils in lungs of nonsmokers with fatal asthma.
112:23-28.e1.
2014
-
Heterogeneity in presentation and treatment of catamenial anaphylaxis.
111:107-111.
2013
-
The effects of particle size on measurement of airway hyperresponsiveness to methacholine.
110:359-363.
2013
-
Asthma maintenance and reliever therapy.
109:388-391.
2012
-
Assessment of specific immunotherapy efficacy using a novel placebo score–based method.
109:342-347.e1.
2012
-
Epinephrine autoinjector delivery systems: An investigation of usability and preference.
107:88-89.
2011
-
Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma.
106:17-23.
2011
-
The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year.
105:174-181.
2010
-
Role of food labels in accidental exposures in food-allergic individuals in Canada.
104:60-65.
2010
-
OCULAR SYMPTOM EFFICACY AND INTRANASAL CORTICOSTEROIDS.
103:539-539.
2009
-
Leptin, adiponectin, and asthma: findings from a population-based cohort study.
103:101-107.
2009
-
Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
102:495-499.
2009
-
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.
100:S30-S40.
2008
-
Hereditary angiodema:: a current state-of-the-art review, VII:: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.
100:S30-S40.
2008
-
Association between exhaled nitric oxide and systemic inflammatory markers.
99:534-539.
2007
-
Association between exhaled nitric oxide and systemic inflammatory markers.
99:334-339.
2007
-
Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data.
97:402-408.
2006
-
Clinical history as a predictor of penicillin skin test outcome.
97:169-174.
2006
-
Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study.
96:666-672.
2006
-
Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.
93:425-430.
2004
-
Interpreting quality of life data: should we listen to the patient or the clinician?.
91:115-116.
2003
-
Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
90:214-222.
2003
-
Omalizumab and the immune system: an overview of preclinical and clinical data.
89:132-138.
2002
-
An unusual case of bilateral auriculotemporal syndrome presenting to an allergist.
89:104-105.
2002
-
Food– and exercise-induced anaphylaxis: importance of history in diagnosis.
89:15-23.
2002
-
Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms.
86:641-648.
2001
-
Quality of life in patients with allergic rhinitis.
85:338-348.
2000
-
A cost-benefit analysis using a willingness-to-pay questionnaire of intranasal budesonide for seasonal allergic rhinitis.
84:55-62.
2000
-
Trends in asthma mortality in young people in southern Brazil.
82:287-292.
1999
-
Tourette's Syndrome in Patients Referred for Allergy Evaluation.
79:347-349.
1997
-
Albuterol via Turbuhaler Versus Albuterol via Pressurized Metered-Dose Inhaler in Asthma.
78:59-63.
1997
-
Relationships between asthma mortality and treatment..
70:425-426.
1993
-
Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire..
70:225-230.
1993
-
Inhaled beta agonists..
68:446.
1992
-
Evaluation of the burden of illness for pediatric asthmatic patients and their parents..
67:403-408.
1991
-
Comparative tolerability of two formulations of Rhinalar (flunisolide) nasal spray in patients with seasonal allergic rhinitis..
61:305-310.
1988
-
Albuterol nebulizer solution for the treatment of asthma..
57:229.
1986
-
Associated cutaneous findings in nickel contact sensitivity..
55:501-503.
1985
-
Hypersensitivity to tobacco glycoprotein in human peripheral vascular disease..
47:8-13.
1981
-
Cutaneous responses to tests with influenza vaccines..
46:183-188.
1981
-
Stimulation of peripheral blood lymphocytes of children by influenza vaccine..
44:263-266.
1980
-
Vitamin A sensitivity..
43:98-99.
1979
-
Clinical evaluation of elixophyllin and choline theophyllinate in the management of chronic asthma; control of the asthmatic attack with a single oral dose of elixophyllin..
16:312-316.
1958
has subject area
Identity
International Standard Serial Number (ISSN)
-
0003-4738
-
1081-1206
-
1534-4436
Electronic International Standard Serial Number (EISSN)